Qilu Pharmaceutical builds a high-end intelligent processing and manufacturing center, with an annual output of up to 10 billion pharmaceutical preparations
The reporter recently learned from Haikou National High-tech Industrial Development Zone (hereinafter referred to as High-tech Zone) that Qilu Pharmaceutical (Hainan) Co., Ltd., a company in the high-tech zone, will build a high-end intelligent processing and manufacturing center project. The overall project is expected to be completed and put into production in December 2022, including purification The plant was completed and put into use in October this year.
On the morning of June 7, the reporter saw in the production workshop of Shizhen Building of Qilu Pharmaceutical (Hainan) Co., Ltd. that workers were transporting and installing a batch of newly-arrived imported equipment, of which 6 were fluidized with a height of about 5 meters. The bed has basically been installed. “This is the key equipment for pharmaceutical production and is used for the drying and drying of pharmaceutical raw materials.” Liu Wenmin, chairman of Qilu Pharmaceutical (Hainan) Co., Ltd., told reporters from Hainan Daily that the imported equipment is from Germany. In addition to the fluidized bed, it also includes coating machines, tablet presses and other equipment, and the technology applied is at a leading level in the world.
"At present, the purification plant has been completed 80%. It is planned to be completed and put into use in October this year. The full intelligent production can reduce the number of personnel from more than 200 to less than 50, which greatly saves human capital." Liu Wenmin told reporters, The production workshop is part of the high-end intelligent manufacturing center project of Qilu Pharmaceutical (Hainan) Co., Ltd. This is another major project invested by Qilu Pharmaceutical Group in Hainan. The total investment is estimated to be nearly 700 million yuan. After completion, it will help pharmaceutical companies achieve stable and over-production and improve production efficiency. The project started construction in March this year and is expected to be completed and put into production in December 2022, with an annual production capacity of 10 billion pharmaceutical preparations.
"After the release of the "Overall Plan for the Construction of Hainan Free Trade Port", it has brought opportunities for enterprise development. We have successively imported a batch of equipment directly from abroad and enjoyed the tariff-free policy. The advanced services and rapid approval of the customs department also make the equipment The import process has also been further accelerated.” Liu Wenmin told reporters that in addition, the business environment of Haikou High-tech Zone is also constantly being optimized. “If difficulties are encountered in the construction of new projects, the High-tech Zone Management Committee will actively coordinate Haikou’s related issues. The department helped us solve the problem so that the project can be carried out smoothly."
"Next, we will increase production and R&D efforts to promote the further development of Hainan's pharmaceutical industry and the construction of Hainan Free Trade Port." Liu Wenmin said.
2026-10-19
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Heavy First Imitation! Qilu Pharmaceutical's 'Aflibercept' Filed For Listing
-
100th! Qilu Pharmaceutical's Cefprozil Was Approved For Marketing And Deemed to Have Passed The Consistency Evaluation
-
Lipoid Kosmetik Announces New U.S. Market Distribution Partnership with Omya
-
An Explosion Has Occurred in the Jubail Industrial City, Putting 6–8% of Global Petrochemical Production Capacity at Risk
-
BASF Technology with CFRP Lands in Nanjing: High-Performance Dispersant Production Line Officially Commissioned
-
Sinopec and LG Chem Sign Agreement to Jointly Develop Sodium-Ion Battery Materials
-
BASF and IFF Collaborate to Accelerate Innovation in Enzymes and Polymers
-
BASF’s Zhanjiang Integrated Site Commissions New Neopentyl Glycol (NPG) Unit
-
Reducing to Refocus: Novo Nordisk’s 9,000-Job Cut and the Strategic Realignment in Pharma
-
BASF's Intensified Moves from May to June: Plant Closures, Divestitures, and Transformation in Sync
Recommend Reading
-
LBB Specialties to Distribute Imerys' Mineral Ingredients in North America
-
When Light Falls on Metal: The Industrial Romance of Xiaomi × BASF
-
Symrise Launches “Care & Wellness” Division to Strengthen Beauty–Health Integration
-
Trump Places Glyphosate Under the Defense Production Act, Turning Bayer from a Corporation into a “National Asset”
-
Trump Places Glyphosate Under the Defense Production Act, Turning Bayer from a Corporation into a “National Asset”
-
Business Society September 22, 2026 Iso-octanol Trend Analysis: Clear Decline
-
Business Society September 22, 2026 Formic Acid Trend Analysis: Clearly Downward
-
Business Society September 21, 2026 Acetic Acid Trend Analysis: Strong Consolidation
-
Business Society September 22, 2026 Acrylic Acid Trend Analysis: Consolidation with a Bias to the Upside
-
Business Society September 21, 2026 BDO Trend Analysis: Volatile Consolidation